• Citer

Recurrent heterozygous PAX6 missense variants cause severe bilateral microphthalmia via predictable effects on DNA–protein interaction

par Williamson, Kathleen K.A.;Hall, Hildegard Nikki;Owen, Liusaidh L.J.;Livesey, Benjamin B.J.;Hanson, Isabel I.M.;Adams, Gillian Gwendolen G.G.W.;Bodek, Simon;Calvas, Patrick;Castle, Bruce;Clarke, Michael;Deng, Alexander A.T.;Edery, Patrick;Fisher, Richard R.S.;Gillessen-Kaesbach, Gabriele;Heon, Elise;Hurst, Jane;Josifova, Dragana;Lorenz, Birgit;McKee, Shane;Meire, Françoise ;Moore, Anthony Thomas;Parker, Michael W;Reiff, Charlotte C.M.;Self, Jay;Tobias, Edward E.S.;Verheij, Joke BGM G M J.;Willems, Marjolaine;Williams, Denise;Van Heyningen, Veronica;Marsh, Joseph Arthur;FitzPatrick, David D.R.
Référence Genetics in medicine
Publication Publié, 2019

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Résumé :

Purpose: Most classical aniridia is caused by PAX6 haploinsufficiency. PAX6 missense variants can be hypomorphic or mimic haploinsufficiency. We hypothesized that missense variants also cause previously undescribed disease by altering the affinity and/or specificity of PAX6 genomic interactions. Methods: We screened PAX6 in 372 individuals with bilateral microphthalmia, anophthalmia, or coloboma (MAC) from the Medical Research Council Human Genetics Unit eye malformation cohort (HGUeye) and reviewed data from the Deciphering Developmental Disorders study. We performed cluster analysis on PAX6-associated ocular phenotypes by variant type and molecular modeling of the structural impact of 86 different PAX6 causative missense variants. Results: Eight different PAX6 missense variants were identified in 17 individuals (15 families) with MAC, accounting for 4% (15/372) of our cohort. Seven altered the paired domain (p.[Arg26Gln]x1, p.[Gly36Val]x1, p.[Arg38Trp]x2, p.[Arg38Gln]x1, p.[Gly51Arg]x2, p.[Ser54Arg]x2, p.[Asn124Lys]x5) and one the homeodomain (p.[Asn260Tyr]x1). p.Ser54Arg and p.Asn124Lys were exclusively associated with severe bilateral microphthalmia. MAC-associated variants were predicted to alter but not ablate DNA interaction, consistent with the electrophoretic mobility shifts observed using mutant paired domains with well-characterized PAX6-binding sites. We found no strong evidence for novel PAX6-associated extraocular disease. Conclusion: Altering the affinity and specificity of PAX6-binding genome-wide provides a plausible mechanism for the worse-than-null effects of MAC-associated missense variants.